Reported Mar 20, 2019 · Terminated
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc,…
Lannett Company Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lannett Company Inc. · 1101 C Ave W · Seymour, IN · 47274-3342
Is this the product you have?
- Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only
- Distributed byLannett Company, Inc, Philadelphia
- PA 19154 NDC62175-271-37
- Lot codes and dates
- Lots
18226783Aexp 07/2021 and 18232540Aexp 08/2021
- Lots
- Amount recalled
- 14,448 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Failed Dissolution Specifications
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lannett Company Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.